Lotus Pharmaceutical Co Ltd (1795) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.029x

Based on the latest financial reports, Lotus Pharmaceutical Co Ltd (1795) has a cash flow conversion efficiency ratio of 0.029x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$701.37 Million ≈ $22.10 Million USD) by net assets (NT$24.31 Billion ≈ $765.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 1795 stock market capitalisation for the company's overall valuation and market capitalisation.

Lotus Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Lotus Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lotus Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lotus Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 1795 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Sino Geophysical SHE:300191	0.017x
Shenzhen Hui Chuang Da Technology Co.Ltd SHE:300909	0.012x
GCS Holdings TWO:4991	0.100x
Globant SA F:2G2	0.079x
Métropole Télévision S.A. PA:MMT	0.027x
Hansol Chemica KO:014680	0.061x
Farglory Land Development Co Ltd TW:5522	0.056x
Fila Holdings Corp KO:081660	0.099x

Annual Cash Flow Conversion Efficiency for Lotus Pharmaceutical Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Lotus Pharmaceutical Co Ltd from 2009 to 2025. View 1795 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$23.78 Billion ≈ $749.20 Million	NT$7.48 Billion ≈ $235.72 Million	0.315x	+8.27%
2024-12-31	NT$21.18 Billion ≈ $667.30 Million	NT$6.15 Billion ≈ $193.91 Million	0.291x	+212.04%
2023-12-31	NT$17.33 Billion ≈ $546.10 Million	NT$1.61 Billion ≈ $50.86 Million	0.093x	-65.28%
2022-12-31	NT$13.87 Billion ≈ $436.91 Million	NT$3.72 Billion ≈ $117.18 Million	0.268x	+2380.88%
2021-12-31	NT$11.07 Billion ≈ $348.73 Million	NT$119.66 Million ≈ $3.77 Million	0.011x	-95.15%
2020-12-31	NT$8.75 Billion ≈ $275.53 Million	NT$1.95 Billion ≈ $61.39 Million	0.223x	+469.83%
2019-12-31	NT$7.74 Billion ≈ $243.97 Million	NT$302.81 Million ≈ $9.54 Million	0.039x	-62.31%
2018-12-31	NT$7.68 Billion ≈ $241.98 Million	NT$796.98 Million ≈ $25.11 Million	0.104x	+34.84%
2017-12-31	NT$7.70 Billion ≈ $242.50 Million	NT$592.29 Million ≈ $18.66 Million	0.077x	-47.82%
2016-12-31	NT$8.36 Billion ≈ $263.42 Million	NT$1.23 Billion ≈ $38.85 Million	0.147x	+19.48%
2015-12-31	NT$8.73 Billion ≈ $275.06 Million	NT$1.08 Billion ≈ $33.95 Million	0.123x	+205.33%
2014-12-31	NT$8.81 Billion ≈ $277.59 Million	NT$-1.03 Billion ≈ $-32.53 Million	-0.117x	-81.88%
2013-12-31	NT$1.49 Billion ≈ $46.87 Million	NT$-95.84 Million ≈ $-3.02 Million	-0.064x	+24.60%
2012-12-31	NT$637.28 Million ≈ $20.08 Million	NT$-54.45 Million ≈ $-1.72 Million	-0.085x	+33.24%
2011-12-31	NT$596.05 Million ≈ $18.78 Million	NT$-76.29 Million ≈ $-2.40 Million	-0.128x	-239.89%
2010-12-31	NT$646.95 Million ≈ $20.38 Million	NT$59.19 Million ≈ $1.86 Million	0.091x	-53.31%
2009-12-31	NT$456.73 Million ≈ $14.39 Million	NT$89.50 Million ≈ $2.82 Million	0.196x	--

About Lotus Pharmaceutical Co Ltd

TW:1795 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

NT$47.50 Billion TWD

Market Cap Rank

#7242 Global

#217 in Taiwan

Share Price

NT$178.50

Change (1 day)

+2.88%

52-Week Range

NT$173.00 - NT$363.00

All Time High

NT$363.00